Thursday, 20 October 2016

European Pharmacopoeia

The European Pharmacopoeia (EP) main volume and supplements are legally binding and details the qualitative and quantitative composition of medicines, the tests to be carried out on medicines, on the raw materials used in the production of medicines and on the intermediates of synthesis.

The EP is a single reference work for the quality control of medicines in Europe. All producers of medicines or substances for pharmaceutical use must apply the quality standards of the European Pharmacopoeia for the marketing and use of these products in Europe.
The EP outlines preparations for pharmaceutical use of chemical, animal, human or herbal origin. It also covers biologicals, blood and plasma derivatives, vaccines and radiopharmaceutical preparations. The monographs give quality standards for all the main medicines used in Europe.
The European Pharmacopoeia is supplied as a subscription only to ensure that subscribers receive all three issues of their purchase. Print supplements are non-cumulative and therefore all previous issues of an edition are required. Electronic supplements are completely cumulative and only the current edition is required.











No comments:

Post a Comment